AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Pharmacogenetics (London)

Results: 1-25/366
COMPARISONS BETWEEN IN-VITRO AND IN-VIVO METABOLISM OF (S)-WARFARIN -CATALYTIC ACTIVITIES OF CDNA-EXPRESSED CYP2C9, ITS LEU(359) VARIANT AND THEIR MIXTURE VERSUS UNBOUND CLEARANCE IN PATIENTS WITH THE CORRESPONDING CYP2C9 GENOTYPES
Authors: TAKAHASHI H KASHIMA T NOMOTO S IWADE K TAINAKA H SHIMIZU T NOMIZO Y MURAMOTO N KIMURA S ECHIZEN H
Citation: H. Takahashi et al., COMPARISONS BETWEEN IN-VITRO AND IN-VIVO METABOLISM OF (S)-WARFARIN -CATALYTIC ACTIVITIES OF CDNA-EXPRESSED CYP2C9, ITS LEU(359) VARIANT AND THEIR MIXTURE VERSUS UNBOUND CLEARANCE IN PATIENTS WITH THE CORRESPONDING CYP2C9 GENOTYPES, Pharmacogenetics, 8(5), 1998, pp. 365-373
INHIBITORY MONOCLONAL-ANTIBODIES TO HUMAN CYTOCHROME-P450 1A2 - ANALYSIS OF PHENACETIN O-DEETHYLATION IN HUMAN LIVER
Authors: YANG TJ SAI Y KRAUSZ KW GONZALEZ FJ GELBOIN HV
Citation: Tj. Yang et al., INHIBITORY MONOCLONAL-ANTIBODIES TO HUMAN CYTOCHROME-P450 1A2 - ANALYSIS OF PHENACETIN O-DEETHYLATION IN HUMAN LIVER, Pharmacogenetics, 8(5), 1998, pp. 375-382
IN-VITRO CHARACTERIZATION OF THE CYTOCHROME-P450 ISOENZYMES INVOLVED IN THE BACK OXIDATION AND N-DEALKYLATION OF REDUCED HALOPERIDOL
Authors: PAN LP DEVRIENDT C BELPAIRE FM
Citation: Lp. Pan et al., IN-VITRO CHARACTERIZATION OF THE CYTOCHROME-P450 ISOENZYMES INVOLVED IN THE BACK OXIDATION AND N-DEALKYLATION OF REDUCED HALOPERIDOL, Pharmacogenetics, 8(5), 1998, pp. 383-389
ROLE OF HUMAN CYTOCHROME-P450 3A4 AND 3A5 IN THE METABOLISM OF TAXOTERE AND ITS DERIVATIVES - ENZYME SPECIFICITY, INTERINDIVIDUAL DISTRIBUTION AND METABOLIC CONTRIBUTION IN HUMAN LIVER
Authors: SHOU MG MARTINET M KORZEKWA KR KRAUSZ KW GONZALEZ FJ GELBOIN HV
Citation: Mg. Shou et al., ROLE OF HUMAN CYTOCHROME-P450 3A4 AND 3A5 IN THE METABOLISM OF TAXOTERE AND ITS DERIVATIVES - ENZYME SPECIFICITY, INTERINDIVIDUAL DISTRIBUTION AND METABOLIC CONTRIBUTION IN HUMAN LIVER, Pharmacogenetics, 8(5), 1998, pp. 391-401
QUANTIFICATION OF INTRAINDIVIDUAL VARIABILITY AND THE INFLUENCE OF MENSTRUAL-CYCLE PHASE ON CYP2D6 ACTIVITY AS MEASURED BY DEXTROMETHORPHANPHENOTYPING
Authors: KASHUBA ADM NAFZIGER AN KEARNS GL LEEDER JS SHIREY CS GOTSCHALL R GAEDIGK A BERTINO JS
Citation: Adm. Kashuba et al., QUANTIFICATION OF INTRAINDIVIDUAL VARIABILITY AND THE INFLUENCE OF MENSTRUAL-CYCLE PHASE ON CYP2D6 ACTIVITY AS MEASURED BY DEXTROMETHORPHANPHENOTYPING, Pharmacogenetics, 8(5), 1998, pp. 403-410
EXPRESSION OF CYTOCHROME P4502E1 IN HUMAN LIVER - ASSESSMENT BY MESSENGER-RNA, GENOTYPE AND PHENOTYPE
Authors: POWELL H KITTERINGHAM NR PIRMOHAMED M SMITH DA PARK BK
Citation: H. Powell et al., EXPRESSION OF CYTOCHROME P4502E1 IN HUMAN LIVER - ASSESSMENT BY MESSENGER-RNA, GENOTYPE AND PHENOTYPE, Pharmacogenetics, 8(5), 1998, pp. 411-421
METABOLISM OF DEXFENFLURAMINE IN HUMAN LIVER-MICROSOMES AND BY RECOMBINANT ENZYMES - ROLE OF CYP2D6 AND 1A2
Authors: HARITOS VS CHING MS GHABRIAL H GROSS AS TAAVITSAINEN P PELKONEN O BATTAGLIA SE SMALLWOOD RA AHOKAS JT
Citation: Vs. Haritos et al., METABOLISM OF DEXFENFLURAMINE IN HUMAN LIVER-MICROSOMES AND BY RECOMBINANT ENZYMES - ROLE OF CYP2D6 AND 1A2, Pharmacogenetics, 8(5), 1998, pp. 423-432
SUSCEPTIBILITY AND OUTCOME IN ORAL-CANCER - PRELIMINARY DATA SHOWING AN ASSOCIATION WITH POLYMORPHISM IN CYTOCHROME-P450 CYP2D6
Authors: WORRALL SF CORRIGAN M HIGH A STARR D MATTHIAS C WOLF CR JONES PW HAND P GILFORD J FARRELL WE HOBAN P FRYER AA STRANGE RC
Citation: Sf. Worrall et al., SUSCEPTIBILITY AND OUTCOME IN ORAL-CANCER - PRELIMINARY DATA SHOWING AN ASSOCIATION WITH POLYMORPHISM IN CYTOCHROME-P450 CYP2D6, Pharmacogenetics, 8(5), 1998, pp. 433-439
SINGLE TUBE MULTIPLEX POLYMERASE-CHAIN-REACTION GENOTYPE ANALYSIS OF GSTM1, GSTT1 AND GSTP1 - RELATION OF GENOTYPES TO TP53 TUMOR STATUS AND CLINICOPATHOLOGICAL VARIABLES IN BREAST-CANCER PATIENTS
Authors: KRISTENSEN VN ANDERSEN TI ERIKSTEIN B GEITVIK G SKOVLUND E NESLAND JM BORRESENDALE AL
Citation: Vn. Kristensen et al., SINGLE TUBE MULTIPLEX POLYMERASE-CHAIN-REACTION GENOTYPE ANALYSIS OF GSTM1, GSTT1 AND GSTP1 - RELATION OF GENOTYPES TO TP53 TUMOR STATUS AND CLINICOPATHOLOGICAL VARIABLES IN BREAST-CANCER PATIENTS, Pharmacogenetics, 8(5), 1998, pp. 441-447
IN-VITRO CYTOCHROME-P450 DEPENDENT METABOLISM OF OXYBUTYNIN TO N-DEETHYLOXYBUTYNIN IN HUMANS
Authors: YAICH M POPON M MEDARD Y AIGRAIN EJ
Citation: M. Yaich et al., IN-VITRO CYTOCHROME-P450 DEPENDENT METABOLISM OF OXYBUTYNIN TO N-DEETHYLOXYBUTYNIN IN HUMANS, Pharmacogenetics, 8(5), 1998, pp. 449-451
PREDISPOSITION TOWARDS UROLITHIASIS ASSOCIATED WITH THE NQ01 NULL-ALLELE
Authors: SCHULZ WA KRUMMECK A ROSINGER I SCHMITZDRAGER BJ SIES H
Citation: Wa. Schulz et al., PREDISPOSITION TOWARDS UROLITHIASIS ASSOCIATED WITH THE NQ01 NULL-ALLELE, Pharmacogenetics, 8(5), 1998, pp. 453-454
HYPOTHESIS - COMPARISONS OF INTERINDIVIDUAL AND INTRAINDIVIDUAL VARIATIONS CAN SUBSTITUTE FOR TWIN STUDIES IN DRUG RESEARCH
Authors: KALOW W TANG BK ENDRENYI L
Citation: W. Kalow et al., HYPOTHESIS - COMPARISONS OF INTERINDIVIDUAL AND INTRAINDIVIDUAL VARIATIONS CAN SUBSTITUTE FOR TWIN STUDIES IN DRUG RESEARCH, Pharmacogenetics, 8(4), 1998, pp. 283-289
N-ACETYLTRANSFERASE NAT1 AND NAT2 GENOTYPES AND LUNG-CANCER RISK
Authors: BOUCHARDY C MITRUNEN K WIKMAN H HUSGAFVELPURSIAINEN K DAYER P BENHAMOU S HIRVONEN A
Citation: C. Bouchardy et al., N-ACETYLTRANSFERASE NAT1 AND NAT2 GENOTYPES AND LUNG-CANCER RISK, Pharmacogenetics, 8(4), 1998, pp. 291-298
DETECTION OF MUTATIONS AND POLYMORPHISM OF N-ACETYLTRANSFERASE-1 GENEIN INDIAN, MALAY AND CHINESE POPULATIONS
Authors: ZHAO B LEE EJD YEOH PN GONG NH
Citation: B. Zhao et al., DETECTION OF MUTATIONS AND POLYMORPHISM OF N-ACETYLTRANSFERASE-1 GENEIN INDIAN, MALAY AND CHINESE POPULATIONS, Pharmacogenetics, 8(4), 1998, pp. 299-304
NAD(P)H-QUINONE OXIDOREDUCTASE - POLYMORPHISMS AND ALLELE FREQUENCIESIN CAUCASIAN, CHINESE AND CANADIAN NATIVE INDIAN AND INUIT POPULATIONS
Authors: GAEDIGK A TYNDALE RF JURIMAROMET M SELLERS EM GRANT DM LEEDER JM
Citation: A. Gaedigk et al., NAD(P)H-QUINONE OXIDOREDUCTASE - POLYMORPHISMS AND ALLELE FREQUENCIESIN CAUCASIAN, CHINESE AND CANADIAN NATIVE INDIAN AND INUIT POPULATIONS, Pharmacogenetics, 8(4), 1998, pp. 305-313
THE RELATIONSHIP BETWEEN CYP1A1 ARYL-HYDROCARBON HYDROXYLASE-ACTIVITYAND LUNG-CANCER IN A JAPANESE POPULATION
Authors: KIYOHARA C NAKANISHI Y INUTSUKA S TAKAYAMA K HARA N MOTOHIRO A TANAKA K KONO S HIROHATA T
Citation: C. Kiyohara et al., THE RELATIONSHIP BETWEEN CYP1A1 ARYL-HYDROCARBON HYDROXYLASE-ACTIVITYAND LUNG-CANCER IN A JAPANESE POPULATION, Pharmacogenetics, 8(4), 1998, pp. 315-323
COMPARISON OF 3 CYP2D6 PROBE SUBSTRATES AND GENOTYPE IN GHANAIANS, CHINESE AND CAUCASIANS
Authors: DROLL K BRUCEMENSAH K OTTON SV GAEDIGK A SELLERS EM TYNDALE RF
Citation: K. Droll et al., COMPARISON OF 3 CYP2D6 PROBE SUBSTRATES AND GENOTYPE IN GHANAIANS, CHINESE AND CAUCASIANS, Pharmacogenetics, 8(4), 1998, pp. 325-333
THE RSAI POLYMORPHISM OF CYP2E1 AND SUSCEPTIBILITY TO ALCOHOLIC LIVER-DISEASE IN CAUCASIANS - EFFECT ON AGE OF PRESENTATION AND DEPENDENCE ON ALCOHOL-DEHYDROGENASE GENOTYPE
Authors: GROVE J BROWN ASM DALY AK BASSENDINE MF JAMES OFW DAY CP
Citation: J. Grove et al., THE RSAI POLYMORPHISM OF CYP2E1 AND SUSCEPTIBILITY TO ALCOHOLIC LIVER-DISEASE IN CAUCASIANS - EFFECT ON AGE OF PRESENTATION AND DEPENDENCE ON ALCOHOL-DEHYDROGENASE GENOTYPE, Pharmacogenetics, 8(4), 1998, pp. 335-342
GENETIC POLYMORPHISMS OF CYP2D6, CYP1A1 AND CYP2E1 IN THE SOUTH-AMERINDIAN POPULATION OF CHILE
Authors: MUNOZ S VOLLRATH V VALLEJOS MP MIQUEL JF COVARRUBIAS C RADDATZ A CHIANALE T
Citation: S. Munoz et al., GENETIC POLYMORPHISMS OF CYP2D6, CYP1A1 AND CYP2E1 IN THE SOUTH-AMERINDIAN POPULATION OF CHILE, Pharmacogenetics, 8(4), 1998, pp. 343-351
NO ASSOCIATION BETWEEN TACRINE TRANSAMINITIS AND THE GLUTATHIONE TRANSFERASE-THETA GENOTYPE IN PATIENTS WITH ALZHEIMERS-DISEASE
Authors: DESOUSA M PIRMOHAMED M KITTERINGHAM NR WOOLF T PARK BK
Citation: M. Desousa et al., NO ASSOCIATION BETWEEN TACRINE TRANSAMINITIS AND THE GLUTATHIONE TRANSFERASE-THETA GENOTYPE IN PATIENTS WITH ALZHEIMERS-DISEASE, Pharmacogenetics, 8(4), 1998, pp. 353-355
THE UGT1A1-ASTERISK-28 ALLELE IS RELATIVELY RARE IN A JAPANESE POPULATION
Authors: ANDO Y CHIDA M NAKAYAMA K SAKA H KAMATAKI T
Citation: Y. Ando et al., THE UGT1A1-ASTERISK-28 ALLELE IS RELATIVELY RARE IN A JAPANESE POPULATION, Pharmacogenetics, 8(4), 1998, pp. 357-360
CHARACTERIZATION OF POLYMORPHISMS IVS25AS-6A TO IVS25AS-6G, C1237T AND T3409C IN THE HUMAN ANGIOTENSIN-CONVERTING ENZYME GENE
Authors: LOW CM YAP EPH LEE EJD
Citation: Cm. Low et al., CHARACTERIZATION OF POLYMORPHISMS IVS25AS-6A TO IVS25AS-6G, C1237T AND T3409C IN THE HUMAN ANGIOTENSIN-CONVERTING ENZYME GENE, Pharmacogenetics, 8(4), 1998, pp. 361-364
GENETIC-ANALYSIS OF THE CYTOCHROME-P450 CYP2D6 POLYMORPHISM IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
Authors: SABBAGH N MAREZ D QUEYREL V LOGUIDICE JM SPIRE C VANHILLE P JORGENSEN C HACHULLA E BROLY F
Citation: N. Sabbagh et al., GENETIC-ANALYSIS OF THE CYTOCHROME-P450 CYP2D6 POLYMORPHISM IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS, Pharmacogenetics, 8(3), 1998, pp. 191-194
ETHNIC-DIFFERENCES IN CATECHOL O-METHYLTRANSFERASE PHARMACOGENETICS -FREQUENCY OF THE CODON-108 158 LOW ACTIVITY ALLELE IS LOWER IN KENYANTHAN CAUCASIAN OR SOUTH-WEST ASIAN INDIVIDUALS/
Authors: MCLEOD HL SYVANEN AC GITHANGA J INDALO A ISMAIL D DEWAR K ULMANEN I SLUDDEN J
Citation: Hl. Mcleod et al., ETHNIC-DIFFERENCES IN CATECHOL O-METHYLTRANSFERASE PHARMACOGENETICS -FREQUENCY OF THE CODON-108 158 LOW ACTIVITY ALLELE IS LOWER IN KENYANTHAN CAUCASIAN OR SOUTH-WEST ASIAN INDIVIDUALS/, Pharmacogenetics, 8(3), 1998, pp. 195-199
ACETYLATION POLYMORPHISM EXPRESSION IN PATIENTS BEFORE AND AFTER LIVER-TRANSPLANTATION - INFLUENCE OF HOST GRAFT GENOTYPES/
Authors: BENDRISS EK BECHTEL YC PAINTAUD G BRIENTINI MP MANTION G MIGUET JP BENNANI A BECHTEL PR
Citation: Ek. Bendriss et al., ACETYLATION POLYMORPHISM EXPRESSION IN PATIENTS BEFORE AND AFTER LIVER-TRANSPLANTATION - INFLUENCE OF HOST GRAFT GENOTYPES/, Pharmacogenetics, 8(3), 1998, pp. 201-209
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>